Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xinning Yang

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Clinical Pharmacology and Therapeutics|April 9, 2021
Do Inhibitory Metabolites Impact DDI Risk Assessment? Analysis of in vitro and in vivo Data from NDA Reviews Between 2013 and 2018Claire Steinbronn, Xinning Yang, Jingjing Yu, et al.
Frontiers in Pharmacology|February 27, 2025
Novel (Q)SAR models for prediction of reversible and time-dependent inhibition of cytochrome P450 enzymesSadegh Faramarzi, Arianna Bassan, Kevin P Cross, et al.
Eye (London, England)|September 15, 2025
Improving the diagnostic efficiency of forme fruste keratoconus by a new combined model with Fourier parameters and corneal epithelial aberrationsRui Ning, Yue Li, Jiawei Li, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 23, 2020
A Novel Physiologically Based Model of Creatinine Renal Disposition to Integrate Current Knowledge of Systems Parameters and Clinical ObservationsDaniel Scotcher, Vikram Arya, Xinning Yang, et al.
Translational Vision Science & Technology|September 11, 2025
Diurnal Variations in Anterior Segment Parameters in Different Grades of Patients With KeratoconusJinxuan Xiahou, Rui Ning, Shuoyu Xu, et al.
Nanoscale Research Letters|August 4, 2021
Enable a Facile Size Re-distribution of MBE-Grown Ga-Droplets via In Situ Pulsed Laser ShootingBiao Geng, Zhenwu Shi, Chen Chen, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 16, 2020
Mechanistic Models as Framework for Understanding Biomarker Disposition: Prediction of Creatinine-Drug InteractionsDaniel Scotcher, Vikram Arya, Xinning Yang, et al.
Clinical Pharmacology and Therapeutics|May 27, 2025
Predicting OCT2/MATEs-Mediated Drug Interactions in Healthy Volunteers and Patients with Chronic Kidney Disease: Insights from Extended Clearance Concept, Endogenous Biomarkers, and In Vitro Inhibition Studies (Perspectives from the International Transporter Consortium)Satoshi Asano, Aleksandra Galetin, Yoshiko Tomita, et al.
Journal of Cataract and Refractive Surgery|February 10, 2026
Agreement Between the ZW-30 SS-OCT Biometer and the MS-39 SD-OCT/Placido Topographer for Anterior Segment MeasurementsChak Seng Lei, Qinghao Meng, Qingyi Gao, et al.
The AAPS Journal|February 15, 2022
Application of Solubility and Dissolution Profile Comparison for Prediction of Gastric pH-Mediated Drug-Drug InteractionsLei Miao, Fang Wu, Xinning Yang, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Clinical Pharmacology and Therapeutics|April 9, 2021
Do Inhibitory Metabolites Impact DDI Risk Assessment? Analysis of in vitro and in vivo Data from NDA Reviews Between 2013 and 2018Claire Steinbronn, Xinning Yang, Jingjing Yu, et al.
Frontiers in Pharmacology|February 27, 2025
Novel (Q)SAR models for prediction of reversible and time-dependent inhibition of cytochrome P450 enzymesSadegh Faramarzi, Arianna Bassan, Kevin P Cross, et al.
Eye (London, England)|September 15, 2025
Improving the diagnostic efficiency of forme fruste keratoconus by a new combined model with Fourier parameters and corneal epithelial aberrationsRui Ning, Yue Li, Jiawei Li, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 23, 2020
A Novel Physiologically Based Model of Creatinine Renal Disposition to Integrate Current Knowledge of Systems Parameters and Clinical ObservationsDaniel Scotcher, Vikram Arya, Xinning Yang, et al.
Translational Vision Science & Technology|September 11, 2025
Diurnal Variations in Anterior Segment Parameters in Different Grades of Patients With KeratoconusJinxuan Xiahou, Rui Ning, Shuoyu Xu, et al.
Nanoscale Research Letters|August 4, 2021
Enable a Facile Size Re-distribution of MBE-Grown Ga-Droplets via In Situ Pulsed Laser ShootingBiao Geng, Zhenwu Shi, Chen Chen, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 16, 2020
Mechanistic Models as Framework for Understanding Biomarker Disposition: Prediction of Creatinine-Drug InteractionsDaniel Scotcher, Vikram Arya, Xinning Yang, et al.
Clinical Pharmacology and Therapeutics|May 27, 2025
Predicting OCT2/MATEs-Mediated Drug Interactions in Healthy Volunteers and Patients with Chronic Kidney Disease: Insights from Extended Clearance Concept, Endogenous Biomarkers, and In Vitro Inhibition Studies (Perspectives from the International Transporter Consortium)Satoshi Asano, Aleksandra Galetin, Yoshiko Tomita, et al.
Journal of Cataract and Refractive Surgery|February 10, 2026
Agreement Between the ZW-30 SS-OCT Biometer and the MS-39 SD-OCT/Placido Topographer for Anterior Segment MeasurementsChak Seng Lei, Qinghao Meng, Qingyi Gao, et al.
The AAPS Journal|February 15, 2022
Application of Solubility and Dissolution Profile Comparison for Prediction of Gastric pH-Mediated Drug-Drug InteractionsLei Miao, Fang Wu, Xinning Yang, et al.
Pageof 5